State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Phytochem Anal. 2021 Nov;32(6):1141-1151. doi: 10.1002/pca.3055. Epub 2021 May 4.
With the wide application of Scutellaria barbata D. Don for hepatitis and mastitis, its quality control issues have also received increasing attention. Based on the multi-component and multi-target characteristics of traditional Chinese medicine, there is an urgent need to establish a quality evaluation system.
This study intends to integrate the "quality-activity-quantification" strategy and establish an activity-related quality control method to ensure the safety and effectiveness of S. barbata.
Ultra-high performance liquid chromatography/ion mobility-quadrupole time-of-flight mass spectrometry (UPLC/IM-QTOF-MS) was used to characterize the chemical components of S. barbata, and network pharmacological analysis was carried out on the identified components. The index components were determined on the basis of comprehensive activity prediction results and content information. At the same time, the contents of 16 batches of S. barbata from different origins were determined.
A total of 94 compounds were identified according to mass spectrometric data, 12 of which were isolated and structure-confirmed by nuclear magnetic resonance technology. Network pharmacological analysis was applied to predict their key targets and the major pathways mediating their anti-inflammatory effects. On the basis of comprehensive activity prediction and content information, five components were chosen as crucial quality indicators of S. barbata, including scutellarin, scutellarein, luteolin, apigenin, and hispidulin.
In this study, 16 different S. barbata batches were compared, and five quality indicators were determined on the basis of qualitative and activity results. The present study provides useful information for evaluating the quality of S. barbata in different areas, and also provides a new basis for the development of quality evaluation methods.
由于黄芩被广泛用于治疗肝炎和乳腺炎,其质量控制问题也受到了越来越多的关注。基于中药的多成分和多靶点特点,迫切需要建立质量评价体系。
本研究旨在整合“质量-活性-定量”策略,建立与活性相关的质量控制方法,以确保黄芩的安全性和有效性。
采用超高效液相色谱/离子淌度-四极杆飞行时间质谱联用技术(UPLC/IM-QTOF-MS)对黄芩的化学成分进行表征,并对鉴定出的成分进行网络药理学分析。在综合活性预测结果和含量信息的基础上,确定指标成分。同时,对来自不同产地的 16 批黄芩进行含量测定。
根据质谱数据鉴定出 94 种化合物,其中 12 种通过核磁共振技术进行了结构确证。网络药理学分析用于预测其关键靶点和介导抗炎作用的主要途径。在综合活性预测和含量信息的基础上,选择 5 种成分作为黄芩的关键质量指标,包括黄芩苷、黄芩素、木樨草素、芹菜素和汉黄芩素。
本研究比较了 16 批不同的黄芩样品,基于定性和活性结果确定了 5 个质量指标。本研究为评价不同产地黄芩的质量提供了有用的信息,也为质量评价方法的开发提供了新的依据。